Use of Abilify (aripiprazole) in adolescents aged 15 years and above with schizophrenia has been approved. The recommended dose in this population is 10mg daily. Use of the drug to treat manic episodes in bipolar disorder remains not recommended under 18 years.
Further information: Otsuka
To sign up for the MIMS monthly news update, register at www.mims.co.uk/bulletins.